Clinton R. Paden

3.7k total citations · 1 hit paper
23 papers, 646 citations indexed

About

Clinton R. Paden is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Clinton R. Paden has authored 23 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Clinton R. Paden's work include SARS-CoV-2 and COVID-19 Research (10 papers), Viral-associated cancers and disorders (8 papers) and Cytomegalovirus and herpesvirus research (8 papers). Clinton R. Paden is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Viral-associated cancers and disorders (8 papers) and Cytomegalovirus and herpesvirus research (8 papers). Clinton R. Paden collaborates with scholars based in United States, United Arab Emirates and Tunisia. Clinton R. Paden's co-authors include Suxiang Tong, Samuel H. Speck, Ying Tao, J. Craig Forrest, Krista Queen, Yan Li, Anna Uehara, Samadhan Jadhao, Larry J. Anderson and Jing Zhang and has published in prestigious journals such as PLoS ONE, Journal of Virology and Genome Research.

In The Last Decade

Clinton R. Paden

22 papers receiving 632 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024

2024 80 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Clinton R. Paden	376	247	153	100	68	23	646
Chiara Terrosi	412 1.1×	228 0.9×	125 0.8×	54 0.5×	91 1.3×	36	797
Antonin Bal	665 1.8×	147 0.6×	51 0.3×	123 1.2×	200 2.9×	42	942
Nungruthai Suntronwong	448 1.2×	279 1.1×	28 0.2×	76 0.8×	137 2.0×	52	686
Veronica Di Cristanziano	499 1.3×	126 0.5×	71 0.5×	126 1.3×	130 1.9×	66	797
Franziska Suter‐Riniker	416 1.1×	288 1.2×	49 0.3×	24 0.2×	88 1.3×	45	729
Mar Mosquera	436 1.2×	289 1.2×	42 0.3×	35 0.3×	26 0.4×	30	629
Tabea Binger	979 2.6×	202 0.8×	36 0.2×	286 2.9×	103 1.5×	20	1.2k
Henning Gruell	782 2.1×	175 0.7×	52 0.3×	69 0.7×	234 3.4×	52	1.2k
Congrong Miao	481 1.3×	431 1.7×	23 0.2×	118 1.2×	40 0.6×	26	843
Alexandre Gaymard	492 1.3×	273 1.1×	20 0.1×	47 0.5×	163 2.4×	30	738

Countries citing papers authored by Clinton R. Paden

Since Specialization

Citations

This map shows the geographic impact of Clinton R. Paden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clinton R. Paden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clinton R. Paden more than expected).

Fields of papers citing papers by Clinton R. Paden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clinton R. Paden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clinton R. Paden. The network helps show where Clinton R. Paden may publish in the future.

Co-authorship network of co-authors of Clinton R. Paden

This figure shows the co-authorship network connecting the top 25 collaborators of Clinton R. Paden. A scholar is included among the top collaborators of Clinton R. Paden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clinton R. Paden. Clinton R. Paden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rose, Erica Billig, Clinton R. Paden, Peter W. Cook, et al.. (2025). Estimated COVID-19 Periodicity and Correlation with SARS-CoV-2 Spike Protein S1 Antigenic Diversity, United States. Emerging infectious diseases. 31(8). 1573–1579.

Kevin, C., Anastasia S. Lambrou, Erica Billig Rose, et al.. (2024). Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages — United States, May 2023–September 2024. MMWR Morbidity and Mortality Weekly Report. 73(42). 938–945. 15 indexed citations

Link‐Gelles, Ruth, Allison Avrich Ciesla, Josephine Mak, et al.. (2024). Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024. MMWR Morbidity and Mortality Weekly Report. 73(4). 77–83. 80 indexed citations breakdown →

Scobie, Heather M., Akilah R. Ali, Philip Shirk, et al.. (2023). Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023. MMWR Morbidity and Mortality Weekly Report. 72(5). 125–127. 6 indexed citations

Babiker, Ahmed, Michael A. Martin, Robert A. Petit, et al.. (2022). Unrecognized introductions of SARS-CoV-2 into the US state of Georgia shaped the early epidemic. Virus Evolution. 8(1). veac011–veac011. 2 indexed citations

Villarino, Elsa, Xianding Deng, Carol A. Kemper, et al.. (2021). Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California. The Journal of Infectious Diseases. 224(2). 207–217. 1 indexed citations

Anderson, Larry J., Samadhan Jadhao, Clinton R. Paden, & Suxiang Tong. (2021). Functional Features of the Respiratory Syncytial Virus G Protein. Viruses. 13(7). 1214–1214. 46 indexed citations

Bhatnagar, Julu, Joy Gary, Sarah Reagan-Steiner, et al.. (2021). Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series. The Journal of Infectious Diseases. 223(5). 752–764. 61 indexed citations

Paden, Clinton R., Ying Tao, Krista Queen, et al.. (2020). Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2. Emerging infectious diseases. 26(10). 2401–2405. 69 indexed citations

10.

Tamin, Azaibi, Krista Queen, Clinton R. Paden, et al.. (2019). Isolation and growth characterization of novel full length and deletion mutant human MERS-CoV strains from clinical specimens collected during 2015. Journal of General Virology. 100(11). 1523–1529. 5 indexed citations

11.

Li, Yan, Ying Tao, Clinton R. Paden, et al.. (2018). Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing. Genome Research. 28(6). 869–877. 58 indexed citations

12.

Queen, Krista, Yassir Mohammed Eltahir, Clinton R. Paden, et al.. (2017). Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates. Emerging Microbes & Infections. 6(1). 1–10. 35 indexed citations

13.

Li, Yan, Abdelmalik I. Khalafalla, Clinton R. Paden, et al.. (2017). Identification of diverse viruses in upper respiratory samples in dromedary camels from United Arab Emirates. PLoS ONE. 12(9). e0184718–e0184718. 30 indexed citations

14.

Abroug, Fekri, Amine Slim, Lamia Ouanes-Besbes, et al.. (2014). Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections, Tunisia, 2013. Emerging infectious diseases. 20(9). 1527–1530. 62 indexed citations

15.

Wakeman, Brian S., L. Steven Johnson, Clinton R. Paden, et al.. (2014). Identification of Alternative Transcripts Encoding the Essential Murine Gammaherpesvirus Lytic Transactivator RTA. Journal of Virology. 88(10). 5474–5490. 10 indexed citations

16.

Krug, Laurie T., Andrew G. Evans, Lisa M. Gargano, Clinton R. Paden, & Samuel H. Speck. (2013). The Absence of M1 Leads to Increased Establishment of Murine Gammaherpesvirus 68 Latency in IgD-Negative B Cells. Journal of Virology. 87(6). 3597–3604. 5 indexed citations

17.

Paden, Clinton R., J. Craig Forrest, Scott A. Tibbetts, & Samuel H. Speck. (2012). Unbiased Mutagenesis of MHV68 LANA Reveals a DNA-Binding Domain Required for LANA Function In Vitro and In Vivo. PLoS Pathogens. 8(9). e1002906–e1002906. 21 indexed citations

18.

Paden, Clinton R., Shweta S. Chavan, Veronica MacLeod, et al.. (2012). Amplification of JNK Signaling Is Necessary To Complete the Murine Gammaherpesvirus 68 Lytic Replication Cycle. Journal of Virology. 86(24). 13253–13262. 20 indexed citations

19.

Liang, Xiaozhen, et al.. (2011). Murine Gamma-herpesvirus Immortalization of Fetal Liver-Derived B Cells Requires both the Viral Cyclin D Homolog and Latency-Associated Nuclear Antigen. PLoS Pathogens. 7(9). e1002220–e1002220. 30 indexed citations

20.

Forrest, J. Craig, et al.. (2007). ORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication. Journal of Virology. 81(21). 11957–11971. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact